Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

12/08/2021 07:00

Aug 12 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               42.93               37.90           165.00    
                   (+13.3 pct)         (+33.4 pct)      (+6.5 pct)  
  Operating            6.08                4.55            17.40    
                   (+33.7 pct)         (-12.7 pct)      (-12.7 pct) 
  Recurring            7.72                4.76            17.60    
                   (+62.2 pct)         (-10.0 pct)      (-5.8 pct)  
  Net                  5.31                3.34            12.00    
                   (+59.1 pct)         (-11.3 pct)      (-14.0 pct) 
  EPS              107.92 yen           67.82 yen       243.83 yen  
  EPS Diluted      105.53 yen           62.70 yen                   
  Ann Div                               44.00 yen        51.00 yen  
  -Q2 div                               22.00 yen        27.00 yen  
  -Q4 div                               22.00 yen        24.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T